Authors
Jiaying Xu, Hao Yang, Yuxi Ma, Zhenting Xiang, Bingying Shi, Siyuan Wang, Kunneng Liang, Yi Deng
Published in
Biotechnology advances. Pages 109097. Nov 09, 2026. Epub Nov 09, 2026.
Abstract
Accurate and dynamic visualization of nucleic acids at the single-molecule level is essential for elucidating cellular processes, defining disease-associated molecular mechanisms, and advancing molecular diagnostics. Conventional imaging methods often lack the sensitivity, specificity, or spatiotemporal resolution required in complex biological systems. Engineered clustered regularly interspaced short palindromic repeats (CRISPR) technologies, leveraging the high programmability of Cas proteins and guide RNAs, have expanded nucleic acid imaging from repetitive and non-repetitive genomic loci to sequence-variant discrimination and individual RNA imaging. This review summarizes major engineering strategies, including Cas protein labeling, guide RNA scaffold modification, and nanomaterial- or protein-assisted signal amplification platforms. We further discuss biomedical applications in live-cell tracking, spatial nucleic acid analysis, and real-time monitoring of cellular dynamics. By examining the biochemical and engineering principles underlying these platforms, we provide a framework for the rational design of CRISPR-based nucleic acid imaging strategies and identify key considerations for overcoming persistent limitations in complex biological environments. Collectively, these advances position engineered CRISPR imaging as a programmable platform for spatially resolved nucleic acid analysis; however, broader application to clinically relevant specimens will require rigorous validation of quantitative robustness and specimen compatibility, together with standardized imaging workflows.
PMID:
43003239
Bibliographic data and abstract were imported from PubMed on 10 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0